Results 111 to 120 of about 308,964 (330)

PROFIL PENGGUNAAN OBAT PASIEN HIPERTENSI ESENSIALDI INSTALASI RAWAT JALAN RUMAH SAKIT UMUM DAERAH I LAGALIGO KABUPATEN LUWU TIMUR PERIODE JANUARI-DESEMBER TAHUN 2014

open access: yesJurnal Farmasi Galenika (Galenika Journal of Pharmacy), 2017
This study aimed to determine the demographic and clinical characteristics and profile of drug use in patients with essential hypertension at outpatient installations I Lagaligo General Hospital East Luwu Regency period January-December 2014.
Senfri Tandililing   +2 more
doaj   +1 more source

Motivational Interviewing Impact on Cardiovascular Disease [PDF]

open access: yes, 2020
: Harm reduction in cardiovascular disease is a significant problem worldwide. Providers, families, and healthcare agencies are feeling the burdens imparted by these diseases.

core  

Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study. [PDF]

open access: yes, 2015
BackgroundThe US Preventive Services Taskforce (USPSTF) recommends routine lipid screening beginning age 35 for men [1]. For women age 20 and older, as well as men age 20-34, screening is recommended if cardiovascular risk factors are present.
Anderson, Melissa L   +6 more
core   +1 more source

High blood pressure, antihypertensive medication and lung function in a general adult population [PDF]

open access: gold, 2011
Eva Schnabel   +10 more
openalex   +1 more source

Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Hypertension is a known modifiable risk factor for Alzheimer’s disease and related dementia (ADRD). However, it is unknown how variance in hypertension control, antihypertensive medications, and social determinants of health, such as social deprivation index (SDI), influence the risk of developing ADRD.
Eissa A. Jafari   +6 more
wiley   +1 more source

Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages

open access: yesiMeta
Dysbiosis of the gut microbiota has been implicated in hypertension, and drug–host–microbiome interactions have drawn considerable attention. However, the influence of angiotensin receptor blocker (ARB)‐shaped gut microbiota on the host is not fully ...
Jing Li   +8 more
doaj   +1 more source

Blood pressure targets in the elderly [PDF]

open access: yes, 2018
No abstract ...
Currie, Gemma, Delles, Christian
core   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou   +7 more
wiley   +1 more source

The antihypertensive effect of orally administered nifedipine‐loaded nanoparticles in spontaneously hypertensive rats [PDF]

open access: bronze, 1997
Young Tae Kim   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy